Moreover, miR‐208a packaged in exosomes from A549 NSCLC cells was demonstrated to act as a transfer messenger and to target p21 with corresponding activation of the AKT/mechanistic target of rapamycin (mTOR) pathway, thereby inhibiting NSCLC cell proliferation.21 Here, AKT1 is linked to non-small cell lung carcinoma.